11243 related articles for article (PubMed ID: 1510801)
1. Influence on metastasis of the reduction of major histocompatibility complex (MHC) class I gene with an antisense oligonucleotide.
Kanbe M; Arita D; Satoh T; Yokoyama A; Murakawa Y; Kikuchi H; Kanamaru R
Anticancer Drug Des; 1992 Aug; 7(4):341-50. PubMed ID: 1510801
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
3. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
Mandelboim O; Vadai E; Feldman M; Eisenbach L
Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
[TBL] [Abstract][Full Text] [Related]
4. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
Alon Y; Hammerling GJ; Segal S; Bar-Eli M
Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
[TBL] [Abstract][Full Text] [Related]
5. Expression of a transfected H-2Kb gene in B16 cells correlates with suppression of liver metastases in triple immunodeficient mice.
Calorini L; Marozzi A; Byers HR; Waneck GL; Lee KW; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1992 Jul; 52(14):4036-41. PubMed ID: 1617680
[TBL] [Abstract][Full Text] [Related]
6. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.
Yamit-Hezi A; Plaksin D; Eisenbach L
Oncogene; 1994 Apr; 9(4):1065-79. PubMed ID: 8134110
[TBL] [Abstract][Full Text] [Related]
7. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.
Ishiguro T; Nakajima M; Naito M; Muto T; Tsuruo T
Cancer Res; 1996 Feb; 56(4):875-9. PubMed ID: 8631027
[TBL] [Abstract][Full Text] [Related]
8. Abolishment of metastasis formation by murine tumor cells transfected with "foreign" H-2K genes.
Gelber C; Plaksin D; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1989 May; 49(9):2366-73. PubMed ID: 2784997
[TBL] [Abstract][Full Text] [Related]
9. Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.
Kim M; Duty L; Herberman R; Gorelik E
Cell Immunol; 1994 May; 155(2):358-71. PubMed ID: 8181071
[TBL] [Abstract][Full Text] [Related]
10. MHC class I genes controlling the metastatic phenotype of tumor cells.
Feldman M; Eisenbach L
Semin Cancer Biol; 1991 Oct; 2(5):337-46. PubMed ID: 1773049
[TBL] [Abstract][Full Text] [Related]
11. Molecular loss variants of the murine major histocompatibility complex: nonexpression of H-2K antigens associated with marked reduction in H-2K mRNA as determined by oligonucleotide hybridization analysis.
Zeff RA; Geier SS; Nathenson SG
J Immunol; 1986 Aug; 137(4):1366-70. PubMed ID: 3734458
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 augmented activation of tumor associated macrophage plays the main role in MHC class I in vivo induction in tumor cells that are MHC negative in vitro.
Ouyang GF; Saio M; Suwa T; Imai H; Nakagawa J; Nonaka K; Umemura N; Kijima M; Takami T
Int J Oncol; 2006 May; 28(5):1201-8. PubMed ID: 16596236
[TBL] [Abstract][Full Text] [Related]
13. H-2K double transfectants of tumor cells as antimetastatic cellular vaccines in heterozygous recipients. Implications for the T cell repertoire.
Mandelboim O; Feldman M; Eisenbach L
J Immunol; 1992 Jun; 148(11):3666-73. PubMed ID: 1588053
[TBL] [Abstract][Full Text] [Related]
14. Developmental expression of H-2K major histocompatibility complex class I transgenes requires the presence of proximal introns.
Drezen JM; Cohen-Tannoudji M; Pournin S; Babinet C; Morello D
Dev Dyn; 1995 Sep; 204(1):98-105. PubMed ID: 8563030
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes.
Hao S; Ye Z; Li F; Meng Q; Qureshi M; Yang J; Xiang J
Exp Oncol; 2006 Jun; 28(2):126-31. PubMed ID: 16837903
[TBL] [Abstract][Full Text] [Related]
16. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
Tashiro-Yamaji J; Kubota T; Yoshida R
Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
[TBL] [Abstract][Full Text] [Related]
17. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
18. Different regulation of class I gene expression in the adult mouse and during development.
Drezen JM; Nouvel P; Babinet C; Morello D
J Immunol; 1992 Jul; 149(2):429-37. PubMed ID: 1624790
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of MHC class I antigen in insulinoma cells controlled by the R1 element of the H-2 enhancer.
Ye X; Kralli A; Ge R; Ricciardi RP; Knowles BB
Oncogene; 1994 Apr; 9(4):1195-204. PubMed ID: 8134122
[TBL] [Abstract][Full Text] [Related]
20. In vivo induction of antitumor immunity and protection against tumor growth by injection of CD154-expressing tumor cells.
Grangeon C; Cormary C; Douin-Echinard V; Favre G; Couderc B; Tilkin-Mariamé AF
Cancer Gene Ther; 2002 Mar; 9(3):282-8. PubMed ID: 11896445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]